Concepedia

Author

Lorenzo Guglielmetti

Sorbonne UniversitéORCID

Also Known As

L Guglielmetti, L. Guglielmetti, Lorenzo Guglielmetti

133

Publications

6.3K

Citations

30

H-Index

26

Concepts

All Affiliations

Sorbonne UniversitéCentre d'Immunologie et des Maladies InfectieusesAssistance Publique – Hôpitaux de ParisInsermResearch Center Borstel - Leibniz Lung Center
LG

About

Lorenzo Guglielmetti is an author at Sorbonne Université specializing in tuberculosis, medicine, and clinical microbiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

1.6K

2

Health Sciences

3

3

42

3

Microbiology

2

2

1.5K

4

Clinical Immunology

1

1

20

5

Immunology

1

1

20

Lorenzo Guglielmetti

×

29

Publications

3.2K

Citations

17

H-Index

YearCitations

Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline

Charles L. Daley, Jonathan M. Iaccarino, Christoph Lange,

European Respiratory Journal

2020

808

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

Charles L. Daley, Jonathan M. Iaccarino, Christoph Lange,

Clinical Infectious Diseases

2020

770

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

Charles L. Daley, Jonathan M. Iaccarino, Christoph Lange,

Clinical Infectious Diseases

2020

739

Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort

Lorenzo Guglielmetti, D. Le Dû, M. Jachym,

Clinical Infectious Diseases

2014

182

Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis

Lorenzo Guglielmetti, Marie Jaspard, Damien Le Dû,

European Respiratory Journal

2016

153

Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis

Lawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison,

Emerging infectious diseases

2019

95

Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis

Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez,

New England Journal of Medicine

2025

54

Availability and costs of medicines for the treatment of tuberculosis in Europe

Gunar Günther, Lorenzo Guglielmetti, Claude Leu,

Clinical Microbiology and Infection

2022

46

Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries

Lorenzo Guglielmetti, Catherine Hewison, Zaza Avaliani,

The International Journal of Tuberculosis and Lung Disease

2017

40

Evidence-based Definition for Extensively Drug-Resistant Tuberculosis

M. Roelens, Giovanni Battista Migliori, Liudmila Rozanova,

American Journal of Respiratory and Critical Care Medicine

2021

35

Page 1